Calcinosis cutis

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Calcinosis cutis | |
|---|---|
| Synonyms | Cutaneous calcification |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Hard, white or yellowish nodules on the skin |
| Complications | Ulceration, infection |
| Onset | Varies depending on underlying cause |
| Duration | Chronic |
| Types | N/A |
| Causes | Hypercalcemia, chronic kidney disease, autoimmune disorders |
| Risks | Scleroderma, dermatomyositis, lupus |
| Diagnosis | Skin biopsy, imaging studies |
| Differential diagnosis | Gout, pseudogout, lipoma |
| Prevention | N/A |
| Treatment | Surgical excision, medications |
| Medication | Diltiazem, warfarin, bisphosphonates |
| Prognosis | N/A |
| Frequency | Rare |
| Deaths | N/A |
Calcinosis Cutis[edit]
Calcinosis cutis is a condition characterized by the deposition of insoluble calcium salts in the skin and subcutaneous tissue. This condition can occur in various forms and is often associated with underlying systemic diseases.
Classification[edit]
Calcinosis cutis is classified into several types based on the underlying cause:
Dystrophic Calcinosis[edit]
Dystrophic calcinosis occurs in the presence of normal serum calcium and phosphate levels. It is often associated with damaged or necrotic tissue. Common causes include connective tissue diseases such as systemic sclerosis, dermatomyositis, and lupus erythematosus.
Metastatic Calcinosis[edit]
Metastatic calcinosis results from elevated serum calcium or phosphate levels, leading to calcium deposition in normal tissues. This type is often seen in conditions such as hyperparathyroidism, chronic kidney disease, and sarcoidosis.
Idiopathic Calcinosis[edit]
Idiopathic calcinosis occurs without any identifiable underlying metabolic disorder. It is often localized and can occur in otherwise healthy individuals.
Iatrogenic Calcinosis[edit]
Iatrogenic calcinosis is caused by medical interventions, such as the extravasation of calcium-containing solutions during intravenous therapy.
Pathophysiology[edit]
The pathophysiology of calcinosis cutis involves the deposition of calcium salts, primarily calcium phosphate, in the skin. This can occur due to local tissue damage, abnormal calcium metabolism, or a combination of both. The deposited calcium can form nodules, plaques, or even large masses, leading to skin ulceration and secondary infection.
Clinical Presentation[edit]
Patients with calcinosis cutis may present with firm, whitish nodules or plaques on the skin. These lesions are often asymptomatic but can become painful if they ulcerate or become infected. The distribution of lesions varies depending on the underlying cause, with common sites including the extremities, joints, and buttocks.
Diagnosis[edit]
The diagnosis of calcinosis cutis is primarily clinical, supported by histopathological examination of skin biopsies. Imaging studies such as X-rays or CT scans can help assess the extent of calcification. Laboratory tests may be conducted to evaluate serum calcium and phosphate levels, especially in cases suspected of metastatic calcinosis.
Treatment[edit]
Treatment of calcinosis cutis focuses on managing the underlying cause and alleviating symptoms. Options include:
- Medical Therapy: Medications such as diltiazem, warfarin, and bisphosphonates may be used to reduce calcium deposition.
- Surgical Intervention: Surgical removal of calcified nodules may be necessary in severe cases.
- Lifestyle Modifications: Patients are advised to avoid trauma to affected areas and maintain good skin hygiene.
Calcinosis Cutis in Animals[edit]
Calcinosis cutis can also occur in animals, particularly in dogs. It is often associated with Cushing's syndrome or prolonged use of corticosteroids. The clinical presentation in animals is similar to that in humans, with firm, calcified nodules on the skin.
See also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian